Mouse Apolipoprotein L9 is a 34-kDa phosphatidylethanolamine (PE)-binding protein. The gene is 25 present only in mouse and rat genomes; hence it is taxonomically restricted. To understand why, it is 26 essential to uncover details about its functions in cellular processes. Here we show that ApoL9 27 interacts with the proteins of the LC3 and GABARAP subfamilies, which are key players in 28 macroautophagy. In amino-acid starved cells it preferentially interacts with lipidated LC3B, likely by 29 binding to its PE moiety. On treatment with autophagy inhibitors bafilomycin A1 and chloroquine, 30
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Introduction predominates contain fewer curved, thread-like structures and vice versa. Thus, the possibility these 114 two patterns are linked cannot be ruled out. 115 We also noticed ApoL9 localizing to ring-like mitochondria, starting approximately 8-10 h post 116 treatment with brefeldin A (Fig. 2D) , an ER stress inducer that inhibits protein transport from the ER 117 to the Golgi apparatus by inhibiting a guanine nucleotide exchange factor GBF1, causing a collapse of 118 the proteins into the ER (Fujiwara et al., 1988; Niu et al., 2005) . ApoL9 was only found on some 119 mitochondria, but not all ( Fig. 2E) , during treatment by either brefeldin A or bafilomycin A1, and this 120 number steadily increased with incubation time with these compounds. ER stress induced by 121 brefeldin A has previously been shown to damage mitochondria by depolarizing them, triggering 122 apoptosis by the classical pathway (Lee et al., 2013) . Bafilomycin A1 has been demonstrated to be a 123 potassium ionophore that leads to impairment of mitochondrial functions by causing them to swell 124 and lose membrane potential (Teplova et al., 2007) . These properties of the compounds, and the 125 considerable time period after which ApoL9 localises to mitochondria in B16F10 L9 cells during 126 treatment with these compounds, are indications that the ApoL9-positive mitochondria might have 127 suffered damage to their integrity. 128
There are clear differences between ApoL9 localization during treatment with bafilomycin A1 and 129 brefeldin A. During treatment with brefeldin A, ApoL9 localizes only to TSPO-positive ring-like 130 structures which are swollen mitochondria. These are often seen clustered together, appearing to be 131 in contact (Fig. 2D) . No localization to lysosomes (Fig. S1 .A) or to curved thread-like structures can 132 be seen. Also, the fluorescence signal from ApoL9 becomes weaker with time, unlike in the case of 133 bafilomycin A1 treatment. 134
In bafilomycin A1-treated cells, LC3B (as GFP-LC3B) accumulates in numerous punctate 135 autophagosomes due to the downstream block in autophagy. ApoL9 does not localize to these 136 structures, suggesting that it is not a part of the autophagosome per se, though transient 137 interactions with autophagosomes might occur (Fig. 2F ). Upon treatment with bafilomycin A1 and 138 brefeldin A, LC3B and GABARAP also appear in the vicinity of mitochondria along with ApoL9, which 139 might indicate that the autophagic machinery is recruited to the damaged mitochondria ( Fig.2G, H,  140 and S1.B). In some cases there appears to be only partial colocalization between ApoL9 and 141 TSPO/LC3B, suggesting that they might be part of more than one structure on or near the 142 mitochondria. But spatial restriction of LC3B/GABARAP localization to ApoL9-positive mitochondria 143 is very clearly evident. The presence of ApoL9 on LAMP-1-positive structures and swollen 6 Another phenomenon observed in cells treated with bafilomycin A1 is the presence of a number of 147 the ApoL9-positive ring-like structures outside the boundaries of the cells that once contained them. 148
They could be seen well outside the boundary of the cells, exiting the membrane (Fig. 2I) , or in close 149 contact with the membrane (before exit), in various images (Fig. S1.C,D) . Mitochondria have 150 previously been described to be ejected from cells undergoing phenomena such as necroptosis and 151 serve as a source of DAMPs (damage-associated molecular patterns) (Maeda and Fadeel, 2014; 152 Krysko et al., 2011) . This study is the first report of ApoL9-containing mitochondria in the 153 extracellular milieu, though it is not clear how much the mitochondria inside the cells and 154 mitochondria outside the cells differ in membrane integrity and protein composition. We didn't 155 observe this phenomenon in cells treated with brefeldin A. 156
ApoL9 accumulates in the Triton X-100-insoluble fraction of lysates of cells treated with 157
bafilomycin A1, but does not seem to be a receptor for selective autophagy 158
In western blots of cell lysates of B16F10 L9 cells treated with bafilomycin A1, there is a gradual 159 decrease of ApoL9 in the Triton X-100 soluble fraction and a corresponding increase in the insoluble 160 fraction (Fig. 3A) , which correlates with the gradual accumulation of ring-like, curved or thread-like 161 entangled structures in the cytoplasm over the same time period. 162 ApoL9 protein levels in B16F10 L9 cells were seen to decrease with time during treatment with 163 brefeldin A (Fig. 3B) . A similar decrease was seen in endogenous ApoL9 in H6 hepatoma cells (Fig.  164   3C) . qPCR from H6 hepatoma cells treated with brefeldin A reveals that there is no decrease in 165
ApoL9 mRNA levels during this treatment, indicating that reduced protein levels are not due to a 166 decrease in the transcription of the Apol9 genes (Fig. 3D) . Further, amino acid starvation of 167 B16F10 L9 cells (treatment with EBSS) led to a decrease in ApoL9 levels with time ( Fig. 3E) . To 168 determine if this decrease was due to autophagy, or if ApoL9 was being degraded as a result of the 169 autophagic process, the cells were treated with the autophagy inhibitor bafilomycin A1 in 170 combination with starvation. Bafilomycin A1 was not able to prevent the decrease in ApoL9 protein 171 levels during amino acid starvation (Fig. 3F) . It is important to note that bafilomycin A1 does not 172 exert its aforementioned effects on the ApoL9 localization pattern during the timescale of the 173 experiment involving starvation with EBSS (6 hours). A similar time-dependent decrease in ApoL9 174 levels was also noticed when B16F10 L9 cells were treated with cycloheximide, an inhibitor of protein 175 synthesis ( Fig. 3G ). Therefore, it seems that the decrease in ApoL9 levels during amino acid 176 starvation or treatment with brefeldin A is reflective of normal turnover of ApoL9 in the cell, likely 177 due to decreased protein synthesis in the cell during starvation and ER stress, rather than the result 178 of autophagic degradation. We have previously shown that ApoL9 is primarily degraded by that was thought to accumulate inside lysosomes and reduce their acidity, but it has recently been 185 determined that chloroquine actually inhibits autophagy by preventing autophagosome-lysosome 186 fusion, in addition to having disorganizing effects on the Golgi and endo-lysosomal systems (Mauthe 187 et al., 2018) . Treatment of B16F10 L9 cells with chloroquine resulted in a clustered pattern of ApoL9 in 188 the cytoplasm. Coupling amino acid starvation with CQ treatment (to induce autophagy and 189 simultaneously prevent autophagic degradation) hastened the formation of these clusters and 190 produced a more pronounced pattern for a given time period as compared with treatment with CQ 191 alone (Fig. 4A ). The ApoL9 in these clusters/vesicles partially colocalized with LAMP1, suggesting 192 that it was interacting with lysosomes or other LAMP1-positive vesicles that are known to be derived 193 from lysosomes (Fig. 4B) . When a cell line stably expressing V5-tagged LC3B (B16F10 LC3B ) was treated 194 with CQ and EBSS, a similar pattern is observed with LC3B displaying partial but slightly higher 195 degree of co-localization with LAMP1-positive structures, indicating that these are autophagic 196 vesicles, since LC3B is primarily a marker of autophagosomes (Fig. 4C ). This clearly indicates that 197
ApoL9 is involved in autophagy triggered by amino acid starvation. Treatment with CQ alone does 198 not lead to a build-up of ApoL9 levels in the cell (Fig. 4D) , nor does CQ prevent the decrease in 199 ApoL9 levels caused by amino acid starvation (Fig. 4E) . Thus it is unlikely that ApoL9 functions as a 200 cargo receptor that is degraded during selective autophagy. 201
Since ApoL9 and LC3B display similar patterns of distribution in amino acid-starved, CQ-treated cells, 202
we decided to examine their interaction during this treatment. HEK293T cells transfected with 203
Apol9-V5 were subjected to amino acid starvation coupled with chloroquine treatment for different 204 time points to prevent autophagic degradation, thereby causing accumulation of LC3-II. When the 205 cell lysates were incubated with anti-V5 agarose to immunoprecipitate ApoL9-V5, LC3B was co-206 immunoprecipitated along with ApoL9. Notably, only the LC3-II form was co-immunoprecipitated 207 ( Fig. 4F) , indicating that ApoL9 has a strong affinity for LC3-II. To corroborate this finding, 208 recombinant MBP (maltose binding protein) and MBP-ApoL9 from E.coli, bound to amylose resin, 209 were incubated with untreated or chloroquine-EBSS-treated HEK293T lysates. Only LC3-II was pulled 210 down by MBP-ApoL9, confirming that ApoL9 interacts preferentially with that form of LC3 (Fig. 4G ).
otherwise no discernible difference between the two LC3 forms. It is also a clear indication that 213
ApoL9 inside the cell interacts with the lipidated form of LC3 during starvation-induced autophagy, 214 thereby having the potential to influence the process. It must be remembered, from Fig.1A , that 215
ApoL9 has a strong affinity for GABARAP and GABARAPL1 even when these proteins are not in their 216 lipidated form. 217
5a. Mutation of a potential LIR motif 67 FPRL 70 weakens association of ApoL9 with GABARAP 218
We have demonstrated that ApoL9 can not only interact with the lipidated form of LC3, but also with 219 nonlipidated LC3 homologues ( Fig. 1A) .To determine if ApoL9 contains an LIR (LC3-interacting 220 region) motif that is usually required for interaction with LC3/GABARAP family members (Birgisdottir 221 et al., 2013) and has the consensus sequence (W/F/Y)-X-X-(L/I/V), where 'X' is any amino acid, we 222 scanned the ApoL9 protein sequence for potential LIRs. Five potential LIRs were identified in the 310 223 amino acid sequence (Fig. 5A) . By site-directed mutagenesis, the codons encoding the 1 st and 4 th 224 (aromatic and hydrophobic) residues of these sequences were mutated to alanines in the ApoL9-V5 225 construct, generating LIR mutants M1-M5. These mutant proteins were expressed in HEK293T cells 226 and tested for binding to GST-GABARAP. LIR mutants M1, M2, M4, and M5 did not alter binding with 227 GABARAP either when mutated singly (Fig. 5B) or when all the four were simultaneously mutated 228 (data not shown). LIR M3, the sequence FPRL (67-70), when mutated to APRA resulted in severely 229 reduced expression of the ApoL9-V5 construct in cells. When lysate quantities were normalized so as 230 to take equivalent quantities of wild type and mutant protein for the GABARAP pull-down assay, it 231 was seen that mutating this sequence reduced binding to GABARAP by about 50% (average of 3 232 experiments) ( Fig. 5C ), indicating that the sequence FPRL (67-70) might function as an LIR in ApoL9. 233
5b. ApoL9 molecules associate with each other 234
We had reported earlier that the subcellular distribution pattern and morphology of ApoL9-GFP 235 fusions differed greatly from that of ApoL9 with smaller epitope tags, probably due to the larger size 236 of GFP (Arvind and Rangarajan, 2016). It was serendipitously observed that electroporation of Apol9-237 GFP into B16F10 L9 cells caused the ApoL9-V5 to redistribute in the typical pattern of ApoL9-GFP ( Fig.  238   5D) , leading us to investigate if both forms of ApoL9 were associating with each other. 239
When MBP and MBP-ApoL9 bound to amylose resin were incubated with lysate of 293T cells 240 expressing ApoL9-V5, it was determined that ApoL9-V5 associated with MBP-ApoL9 but not with 241 MBP alone (Fig. 5E ). Further, immunoprecipitation of ApoL9 from lysates of cells transfected with 242 two forms of ApoL9 (ApoL9-V5 and ApoL9-3XFLAG) demonstrated that ApoL9-3XFLAG could be 9
The ApoL proteins are BH3-only proteins, as they contain a putative BH3 domain that is 245 characteristic of the Bcl-2 family of proteins (Kreit et al., 2015) . Since BH3 domains are known to be 246 involved in homo-and hetero-oligomerization between proteins containing them (Kale et al., 2018) , 247 we tested whether deleting the core region of the BH3 domain of ApoL9 (amino acids 81-89) would 248 affect association between ApoL9 molecules. The results indicated that MBP-ApoL9-BH3 was 249 severely impaired in its ability to interact with ApoL9-V5, when compared with wild type MBP-250
ApoL9. (Fig.5G ). This indicated that the BH3 domain is involved in oligomerization of ApoL9 251 molecules. However, more pull-down experiments (next section) reveal that mutations in some 252 other regions also abolish the ability to associate with wild type ApoL9-V5, indicating that the 253 necessary for association/oligomerization might be spread over a wider region of the protein 254 sequence. 255
Identification of the PE-binding region of ApoL9 256

6a. Deletion of amino acids in a putative transmembrane region of ApoL9 abolishes binding to PE 257
To identify the region of ApoL9 responsible for interaction with PE, we generated a series of mutants 258 carrying deletions in the ApoL9a protein sequence 
6b. Non-PE-binding mutants of ApoL9 differ in some of the properties exhibited by wild type ApoL9 270
We subjected B16F10 cells expressing either ApoL9-V5-111-123 or ApoL9-V5-124-144 to various 271 treatments to see which of the properties displayed by wild type ApoL9 were abolished by deletions 272 in the transmembrane region involved in binding PE. We had reported previously that lipofection of 273 any plasmid into B16F10 L9 cells caused rapid and dramatic aggregation of ApoL9 due to its 274 propensity to interact with dioleoylphosphatidylethanolamine (DOPE) in the transfection reagent 275 (Arvind and Rangarajan, 2016) . So, firstly, lipofection of an empty (insert-less) plasmid into cells 276 stably expressing these mutants (B16F10 L9111-123 or B16F10 L9124-144 ) did not result in aggregation of 277 ApoL9, confirming that these mutants were unable to interact with the DOPE in Lipofectamine 2000 278 ( Fig. 6B) . Secondly, the alterations of ApoL9 distribution in the cells when treated with bafilomycin 279 A1 and brefeldin A, notably the mitochondrial localization of ApoL9 and curved, thread-like 280 structures, were not seen in the mutants (Fig. 6C, D) . Interestingly, localization to juxtanuclear 281 lysosomes was still observed in bafilomycin A1 treated cells (Fig. 6E) . Further, the clustered pattern 282 of ApoL9 is not seen when treated with chloroquine-EBSS for shorter time periods, but localization 283 to lysosomes persisted on long-term treatment with chloroquine ( Fig. S3.A) , suggesting that lipid-284 binding is not linked to lysosomal localization per se, but is still involved in starvation-induced 285 changes in ApoL9 distribution. An interesting observation was that ApoL9-V5-124-144 formed 286 aggresomes on MG132 treatment but ApoL9-V5-111-123 did not (compare Fig. 6C and 6D) . This 287 was also reflected in the observation that protein levels of ApoL9-V5-111-123 remained more or 288 less unchanged over time on treatment with brefeldin A or cycloheximide, indicating poor turnover, 289 while those of ApoL9-V5-124-144 decreased gradually with time ( Fig. S3 .B,C), suggesting that the 290 region between amino acids 111 and 123 contains residues critical for facilitating proteasomal 291 degradation of ApoL9. Also, interaction with GABARAP remained undisturbed in both the mutants 292 ( Fig. S3.D) , indicating that the transmembrane region had no role in mediating that interaction. On 293 the other hand, both mutant proteins lost the ability to associate with wild type ApoL9 (Fig. S3.E) , 294
indicating that the intactness of the region is a requisite for oligomerization to happen. A minor note 295 to make is that ApoL9111-123 displays anomalous mobility in SDS-PAGE and migrates slightly 296 slower than wild type ApoL9 despite having a lower molecular mass. 297
ApoL9 is a microtubule-associated protein 298
We know that lipofection of an empty (insert-less) plasmid into B16F10 L9 cells causes ApoL9-V5 to 299 aggregate in the cytoplasm (Arvind and Rangarajan, 2016; and Fig. 6B ). But lipofection of an ApoL9-300 V5-expressing plasmid into B16F10 cells presents a markedly different picture. In addition to a few 301 aggregates, ApoL9 is seen in several long, thin, fibre-like structures (Fig. 7A) . Further, 302 electroporation of ApoL9-V5 into cell lines such as HepG2 and HEK293T (which express high 303 quantities of protein) also resulted in such structures becoming visible (Fig. 7B) , ruling out that these 304 structures were another artefact of lipofection of ApoL9. Instead, we think that they are probably 305 formed as a result of high levels of ApoL9 protein expression, since lipofection is a remarkably 306 efficient transfection method that facilitates the expression of very high levels of protein per cell. and a microtubule-stabilizing agent respectively. All fibre-like structures disappeared in ApoL9-310 lipofected cells after a three-hour nocodazole treatment, while their abundance increased (including 311 in the cell periphery) on paclitaxel treatment (Fig. 7C) , indicating that ApoL9 localizes to 312 microtubules. Further, treatment of the B16F10 L9 cell line with paclitaxel led to ApoL9-V5 becoming 313 visible on microtubules, which had become stabilized due to the effect of the drug (Fig. 7D ). Another 314 observation was that treatment of B16F10 L9 cells with nocodazole greatly increased the number of 315 ALIS-like structures in the cytoplasm (Fig. 7D ), suggesting that the dynamics of ALIS in the cell are 316 regulated by microtubules and that attachment to microtubules might be involved in trafficking of 317 ApoL9 within the cell. Microtubule association was further confirmed by co-localization of ApoL9 318 with -tubulin in paclitaxel-treated cells (Fig. 7E) . Also, GFP-tagged -tubulin could be co-319 immunoprecipitated with ApoL9-V5 from HEK293T cells transfected with both these proteins ( Fig.  320 7F), confirming that ApoL9 is a microtubule-associated protein (MAP). Both transmembrane deletion 321 mutants of ApoL9 failed to associate with microtubules, as evident from their immunofluorescence 322 pattern after treatment with paclitaxel, displaying no co-localization with tubulin ( Fig. S4 .A). We 323 have sometimes seen the presence of -tubulin in the curved, thread-like structures formed during 324 bafilomycin A1 treatment (Fig. 7G) . This observation has been sporadic and is not readily evident in 325 the majority of cells. But it probably suggests that microtubules are associated with these structures 326 at a certain point in the process of their formation, and might later dissociate from them. It is 327 pertinent to note that LC3B and its orthologues are also microtubule-associated proteins. It has been 328 shown previously that the first 22 amino acids of GABARAP have basic residues clustered on one side 329 of a helix that serves as a tubulin-binding motif (Wang and Olsen, 2000) . ApoL9 being a protein that 330 mostly comprises helices in its secondary structure, we examined it for helices enriched in basic 331 residues. The region between amino acids 54 and 70, when visualized as a helical wheel, is part of a 332 helix with at least four basic residues (lysines) clustered on one side (Fig. 7H) . These lysines are also 333 conserved in the rat orthologue of ApoL9a ( Fig. S4.B) . Further investigations will be needed to reveal 334 if this region indeed binds tubulin and, if yes, to elucidate structural details of the interaction. 335
ApoL9 redistributes to stress granules under certain conditions of stress 336
When B16F10 L9 cells were subjected to heat stress by incubating them at 43˚C for 30 minutes, 337
ApoL9-V5 was seen to redistribute into a large number of granules in the cytoplasm. It was obvious 338 that these granules might be different from ALIS, due to their irregular size and shape, and higher 339 number. In addition to heat stress, we found that other conditions such as oxidative stress induced 340 by sodium arsenite or DTT (but not H 2 O 2 ), and ER stress induced by thapsigargin, also caused the 12 localization of ApoL9 with the well-known stress granule markers eIF3 (eukaryotic initiation factor 343 3) and TIA-1 (T-cell intracytoplasmic antigen 1) ( Fig. 8A, Fig. S4 .C). To confirm that ALIS and stress 344 granules were indeed different, we looked at the localization of SQSTM1 after thapsigargin 345 treatment. Double immunofluorescence showed that SQSTM1 localised to other granules but wasn't 346 present with ApoL9 in stress granules, confirming that these granules are not ALIS but bona fide 347 stress granules Fig. 8C. Curiously, these two granule types were in close apposition in many 348 locations in the cytoplasm, which could point towards a potential for interaction between their 349
components. 350
Neither of the transmembrane deletion mutants of ApoL9 (ApoL9 111-123 or ApoL9 124-144 ) 351 redistributed to these granules on subjecting to stress treatments, as evidenced by complete lack of 352 co-localization with eIF3Fig. S.4D. 
The possible implications of the ApoL9-LC3/GABARAP interaction 361
One of the important results in this study is the demonstration of a direct interaction between the 362 lipidated form of LC3 and ApoL9 during starvation-induced autophagy. However, we do not observe 363
ApoL9 concentrated on the numerous punctate autophagosomes that appear in the cell during this 364 process, indicating that it is not an inherent part of the autophagosome. It is likely that ApoL9 365 transiently interacts with the expanding phagophore/maturing autophagosome. Further, ApoL9 also 366 interacts with the non-lipidated forms of LC3 and its homologues, with highest affinity for GABARAP 367 and GABARAPL1. Though we couldn't identify an LIR that completely abolished interaction with 368 GABARAP, it is worth noting that the key residues of the LIR motif candidate 67 FPRL 70 , mutation of 369 which reduced binding to GABARAP by >50%, are also conserved in rat ApoL9a. 
Could ApoL9 influence mitophagy? 390
The fact that the PE-binding ability of ApoL9 is abolished by the deletion of a putative 391 transmembrane domain is directly indicative of the likelihood of the protein binding to PE embedded 392 in lipid bilayers/membranes. Localization to swollen mitochondria during treatment with brefeldin A 393 and bafilomycin A1 is also abolished in these deletion mutants ApoL9111-123 and ApoL9124-144. 394
Since the bulk of the PE in the cell is synthesised in the mitochondria by decarboxylation of 395 phosphatidylserine (Borkenhagen et al, 1961; Shiao et al., 1995) , it is not surprising to find ApoL9 in 396 mitochondria (though it is not detected there in steady state conditions). The outer mitochondrial 397 membrane (OMM) is known to have a plethora of pro-and anti-apoptotic proteins of the Bcl-2 398 family that regulate mitochondrial integrity and physiology (Harris and Thompson 2000) . We have 399 observed ApoL9 forming complete rings around mitochondria, and incomplete 'crescents' around 400 some ( Fig. 2A, 2D , and S4.E), suggesting the possibility that ApoL9 molecules might gradually 401 colonize the mitochondrial membrane. This is reflected in a few images where the parts of the 402 membrane densely stained for TSPO are weakly stained for ApoL9, and vice versa (Fig. S4.E) . It is 403 common knowledge that autophagosomes are of different sizes depending on the cargo that is 404 targeted for degradation. For quite some time, it has been known that the mitochondria are one of 405 the various sources that contribute membrane to form autophagosomes by membrane addition 406 be important to generate autophagosomes from mitochondria. They also note that during 411 autophagy, a significant quantity of membrane moves from autophagosomes to lysosomes through 412 fusion, and that PE comprises a large fraction of this. To the best of our knowledge, this study 413 reports the first instance of a PE-binding protein that has been observed localizing to mitochondria 414 synchronously with proteins of the autophagic machinery, and co-localizing with them. Another 415 connection worth noting is that ApoL9 has been reported to interact with PHB1 and PHB2 (Kreit et 416 al., 2015) , two proteins of the inner mitochondrial membrane (IMM) that have been implicated in 417 controlling IMM organization by acting as protein and lipid scaffolds (Osman et al., 2009 ). Further, 418 PHB2 has been identified to function as a receptor for mitophagy on the IMM by bridging LC3 and 419 depolarized mitochondria whose outer membranes have ruptured (Wei et al., 2017). How ApoL9 420 could fit in this complex scheme of events is a topic for future study. 421
It has been reported (Maeda and Fadeel, 2014) that intact mitochondria could be expelled from 422 cells undergoing TNF--induced necroptosis and that this appeared to happen before the disruption 423 of the plasma membrane, suggesting an active mechanism of release. Several other reports have 424 also suggested that molecules derived from mitochondria and other organelles can act as DAMPs 425 (damage-associated molecular patterns) that act as signals for other cells in the immune system 426 
In what way could a lipid-binding MAP influence autophagy? 457
The ability of ApoL9 to associate with microtubules might influence several cellular functions of the 458 protein, because it can potentially ferry lipid, or other, molecules to various parts of the cell while 459 attached to microtubules. Like several other MAPs (Itoh and Hotani, 1994) , ApoL9 seems to stabilize 460 microtubules by binding to them, since mere overexpression of ApoL9 is sufficient for stabilized 461 microtubules to become visible in the cytoplasm. ApoL9 seems to be directly and strongly associated 462 with microtubules unlike proteins like LC3B that associate indirectly by virtue of their association 463 with other MAPs, since treatment of the B16F10 LC3B cell line with paclitaxel does not result in LC3B 464 becoming visible on stabilized microtubules in the cytoplasm (Fig. S4.F) . We could co-465 immunoprecipitate -tubulin with ApoL9, but since tubulin forms heterodimers further 466 investigations are needed to determine which tubulin types ApoL9 associates with and what the 467 structural details of the interaction are. It is interesting to observe that the helical region comprising 468 amino acids 54-70 that is a potential tubulin-binding motif lies exactly adjacent to FPRL, the potential 469 LIR motif of ApoL9 which when mutated reduced association with GABARAP by >50%. GABARAP 470 itself is a tubulin-binding protein, and it is not inconceivable that ApoL9 might simultaneously 471 associate with microtubules and GABARAP under certain conditions. Autophagosomes and lysosomes are known to specifically travel along microtubules that undergo specific types of post-473 translational modifications (Xie et al., 2010; Mohan et al., 2018); therefore it might be of interest to 474 investigate if ApoL9 localization is restricted to some or other subset of microtubules. 475
The identity of the highly curved, thread-like structures that accumulate in the cytoplasm after 476 prolonged treatment with bafilomycin A1 is unclear, as they did not co-localize with any protein or 477 organelle marker we used. Since their increase in the cell correlates with ApoL9 fractionating into a 478 Triton X-100-insoluble fraction of the lysate, it is possible that they comprise only ApoL9 and 479 membranous material. ApoL9 localizes to lysosomes on treatment with bafilomycin A1 or CQ, and 480 this property is not abolished in the non-PE-binding mutants suggesting that PE-binding is not 481 necessary for lysosomal localization. The C-terminus of ApoL9 contains the sequence YKTI, which 482 corresponds to a known consensus for lysosomal membrane targeting (YXX) (Guarnieri et al., 483 1993). ApoL9 seems to be targeted to lysosomes only under certain conditions, because in normal 484 conditions it doesn't seem to accumulate in these organelles. This points to the possibility of ApoL9 485 being involved in the later stages of autophagy, when autophagosomes mature and autolysosomes 486 come into play. The thread-like structures do not accumulate in cells expressing the non-PE-binding 487 mutants; it is likely that these structures are formed as a result of the prolonged downstream block 488 in the autophagic process due to the action of bafilomycin A1. It is widely accepted now that the 489 terminal step of autophagy is a process called autophagic lysosome reformation, in which a clathrin-490 based budding mechanism facilitates the growth and elongation of tubules from autolysosomes 491 However, it is still very unclear how different phospholipids regulate this mechanism, and how 493 lysosomal membrane and luminal proteins are sorted in this process. In our study, as mentioned 494 before, we have noticed a negative correlation between the presence of ApoL9 in juxtanuclear 495 lysosomes and in curved thread-like structures. We have also occasionally observed microtubule 496 proteins co-localizing with these structures. Therefore, we speculate that ApoL9, being a MAP and 497 an oligomerizing PE-binding protein, might regulate the formation of these or other similar tubules 498 from the lysosomes, thus potentially recycling membrane components for autophagy. It is 499 interesting to note that these ApoL9-positive curved, thread-like structures are seen only in 500 bafilomycin A1-treated cells but not in CQ-treated cells, and that the positioning of lysosomes in the 501 former case tends to be predominantly juxtanuclear. This may reflect the differences in the 502 mechanism of autophagy inhibition by these two compounds. 503
Taken together, the data presented in this study demonstrates that ApoL9 is a rather dynamic 504 protein that is found in several distinct compartments in the cell and interacts with various cellular 505 molecules. It is reasonable to speculate that it is involved in lipid transport in the cell and that its role 506 in autophagy is likely to be that of an adaptor protein. Since it is restricted to two species of rodents 507 and its expression levels are tissue-specific, it is unlikely to be an essential protein for autophagy and 508 we propose that it might confer some very selective advantage to rodent-specific metabolic 509 activities. One of the most significant differences between bigger and smaller animals is the high 510 metabolic rate per unit weight in the latter (Klieber, 1947) . Assuming that ApoL9 has a small but not 511 insignificant contribution in augmenting a process such as protein homoeostasis or autophagy, and 512 considering its high levels in liver and brain tissue where autophagy plays critically important roles in 513 maintaining organ homoeostasis, it is possible to envisage a scenario where expression of such a 514 gene could confer a definite advantage to the fitness of a fast-metabolising species such as mouse. 515
Therefore we also feel that it would be appropriate if further investigations regarding ApoL9 be 516 performed in an in vivo context where its functions might be understood even better, like in hepatic 517 or neuronal tissues and in knockout mice. 518
519
MATERIALS AND METHODS
520
Cell lines and reagents 521 B16F10 mouse melanoma was obtained from the tissue culture facility, Dabur Research Foundation, 522
Ghaziabad, India. Mouse hepatoma H6 has been described ( Thompson et al., 1981) and referenced 523 (Nandi et al., 1996) previously. HEK293T (ATCC® CRL 3216™) and HepG2 (ATCC® HB-8065™) were 524 gifts from Prof. Ganesh Nagaraju and Prof. Anjali Karande, Indian Institute of Science, Bangalore, 525
India. All cell lines were cultured in high glucose Dulbecco's Modified Eagle's Medium (DMEM) 526 containing 10% foetal bovine serum (FBS) and an antibiotic mixture comprising 10,000 units/mL 527 penicillin, 10,000 g/mL streptomycin, and 25 g/mL amphotericin B. The cell lines were maintained 528 in an incubator at 37˚C with 5% CO 2 and water provided for humidification. All cell lines were 529 routinely inspected for the absence of any potential contamination, including mycoplasma. polyclonal anti-MBP-ApoL9 antibody has been described and validated earlier in (Arvind and 557 Rangarajan, 2016) . Also it should be noted that, in the bulk of experiments in the paper, ApoL9-V5 558 was detected in immunostaining and immunoblotting by anti-V5 antibody, unless specifically 559 mentioned otherwise. 560
Plasmids and constructs 561
The Apol9a gene was amplified as described earlier (Arvind and Rangarajan, 2016) from cDNA 562 prepared from total RNA of B16F10 cells treated with type I interferon. ORFs for other genes were 563 amplified from cDNA prepared from various mouse tissues/cell lines according to level of expression. 564
The Apol9-V5 and Apol9-3XFLAG constructs were made by cloning the cDNAs into the XbaI and 565
HindIII sites in the vector pBApo-EF1 pur (Takara Bio Inc., Kusatsu, Shiga Prefecture, Japan). The V5 566 sequence was included in the reverse primer, while the 3XFLAG sequence was amplified from the 567 vector p3XFLAG-CMV-10 (Sigma-Aldrich). The MBP-ApoL9 construct was made by cloning Apol9a 568 amplified from the Apol9-V5 construct and cloning into the SalI and HindIII sites in the vector pMAL-569 an N-terminal V5 tag into the BamHI and HindII sites of pBApo-EF1 pur. To create GFP-fusion 575 constructs Lc3b (EcoRI/BamHI) and Gabarap (HindIII/BamHI) were also cloned into the vector 576 pEGFP-C1 (Clontech Laboratories, Mountain View, California, USA). N-and C-terminal GFP fusions of 577 ApoL9 were created by cloning Apol9a into pEGFP-C1 (HindIII/KpnI) and pEGFP-N1 (HindIII/ApaI) 578 respectively. The plasmid expressing GFP-tagged alpha tubulin was a gift from Prof. Vaishnavi 579 Ananthanarayanan, Centre for BioSystems Science and Engineering, IISc, Bangalore, India. 580
Translocator protein (Tspo) was cloned into the HindIII and BamHI sites of pEGFP-N1. Tia-1 was 581 cloned into the EcoRI and BamHI sites of p3XFLAG-CMV-10. 582
LIR mutants and deletion constructs 583
LIR mutants of Apol9-V5 were created by using complementary primers containing the desired 584 mutations in the region of the potential LIR, using wild type Apol9-V5 to create amplicons with an 585 overlapping sequence, followed by overlap extension PCR to make the final mutant construct, and 586 cloning into the HindIII and XbaI sites of pBApo-EF1 pur. 587
Similarly, deletions in the MBP-Apol9 sequence were made by using complementary primers 588 containing a deletion in the region of the desired deletion, followed by overlap extension PCR. The 589 constructs were cloned into the SalI and HindIII sites in the vector pMAL-c2X. The WT MBP-Apol9 590 construct was used as template for the initial rounds of PCR. To create Apol9-V5 (111-123) and 591
Apol9-V5 (124-144), the inserts were amplified from the respective MBP-Apol9 constructs and 592 cloned into the XbaI and HindIII sites of pBApo-EF1 pur. All clones were sequenced to confirm for 593 the desired mutations or deletions. 594
The various deletions are described and shown schematically (Fig. S2.A,B) .The N-terminal deletion 595 was 54 amino acids, spanning the full length of the helices in that region. The C-terminal deletion 596 was 30 amino acids in length which corresponded to a predicted coiled coil sequence in that region. 597
The BH3 deletion mutant encompassed amino acids 81-89, the core BH3 domain consensus 598 sequence. Based on predictions from software that predict transmembrane sequences in proteins 599 (Cserzo et al., 1997) , two deletions were made that encompass potential transmembrane regions on 20 in the remaining regions of the sequence, with no deletion exceeding an average length of 20-25 602 amino acids. Two exceptions were made based on exact stretches of 3 amino acids being present in 603 mouse PEBP1 and human PEBP4, respectively, both being proteins of the 604 phosphatidylethanolamine-binding protein family. 605
Creation of cell lines stably expressing protein 606
The B16F10 cell line stably expressing ApoL9 (B16F10 L9 ) has been described previously (Arvind and 607 Rangarajan, 2016) . Briefly, the ApoL9-V5 construct in pBApo-EF1 pur was linearized using ScaI and 608 transfected into semi-confluent B16F10 cells using Lipofectamine 2000. 48 h later, the cells were 609 subcultured into six-well plates and transformants were selected with 2 g/mL puromycin. Ten days 610 later, single colonies were picked using sterile PYREX® cloning cylinders (6 mm x 8 mm, Corning Inc., 611
Corning, New York, USA) and expanded into cultures in 6-well plates. The colonies were screened for 612
ApoL9 expression by indirect immunofluorescence using anti-V5 antibody, and clones with an 613 optimum level of expression were further expanded and frozen. B16F10 LC3B , B16F10 L9111-123 and 614 B16F10 L9124-144 were made by a similar procedure, using the V5-LC3B, ApoL9-V5111-123 and 615
ApoL9-V5124-144 constructs. 616
Transfection procedures 617
Lipofectamine 2000 was used according to the manufacturer's instructions. Electroporation was 618 done using Bio-Rad Gene Pulser™ electroporation cuvettes (0.4 cm gap; blue) and the Gene Pulser 619
Xcell™ electroporation system. Briefly, confluent B16F10 cells in a T75 culture flask were trypsinized 620 and centrifuged at 350 g. The cells were resuspended homogeneously in 2.5 mL Opti-MEM reduced 621 serum medium. 400 L of cell suspension was mixed with 5-10 g of plasmid DNA and ~20-30 g of 622 sterile, sonicated calf thymus DNA, added to the cuvette and pulsed using the exponential decay 623 protocol at 240V and 950F capacitance. The electroporated cell suspension was added to 1.2 mL 624
Opti-MEM in 35 mm culture dishes with or without glass cover slips. The medium was replaced with 625 fresh medium 4-6 h post electroporation, and the cells were processes for downstream experiments 626 16-24 h post transfection. 627
Calcium phosphate transfection was performed as described in (Sambrook and Russell, 2005) with 628 minor modifications. This technique was primarily used for HEK293T cells. Briefly, the growth 629 medium of cells (70% confluent) was replaced with 4 mL Opti-MEM just prior to transfection. For 630 transfection of a 60 mm dish, a cocktail was made that contained 8 g plasmid DNA, ~30 g calf 631 thymus DNA, and 22 L of 2M CaCl 2 made up to 180 L with water. To this, 180 L of 2X Hepes-mixture was incubated for 20 minutes and then added to the cells gently. The transfection medium 634 was replaced with fresh medium exactly 4 h post transfection, and the cells were processed for 635 downstream experiments ~24 hours after transfection. all cell treatments, the addition of DMSO to cells never exceeded 0.1%. Chloroquine was dissolved in 704 water to make a 10 mM stock solution. Heat stress was applied by keeping cells in a CO 2 incubator 705 set at 43˚C for 30 min. Sodium arsenite was added to cells at 0.5 mM for 30 min. DTT was added to 706 the cells at 2 mM, from a freshly prepared stock solution in water. Thapsigargin was used at 500 nM 707 for 1 h, from a 1.5 mM stock solution in methanol. Bafilomycin A1 was used at 200 nM for 708 appropriate time periods, unless mentioned otherwise. Brefeldin A was used at 10 g/mL. 709
Chloroquine was used at 50 M. EBSS treatment of cells was done by washing the cells with EBSS 710 twice after removing the normal culture medium, and culturing in fresh EBSS for the stipulated time 711 periods. Paclitaxel was dissolved in DMSO to make a 10 mM stock and used to treat cells at 10 M. 712
Nocodazole was dissolved in DMSO to make a 10 mg/mL stock and used to treat cells at 10 g/mL. 713 MG132 was dissolved in DMSO to make a 10 mM stock and used to treat cells at 10 M for 6 hours. 714
Cycloheximide was dissolved in water to make a 10 mg/mL stock and used at a concentration of 50 715 g/mL in the chase assay. from stress granules (stained with anti-V5 antibody). Note the proximity between both types of granules in the magnified inset.
